{"filing":{"accession_number":"0001731122-26-000957","cik":"0001314052","ticker":"AVXL","company_name":"ANAVEX LIFE SCIENCES CORP.","form":"8-K","filing_date":"2026-07-20","report_date":null,"primary_document":"e7790_8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000957/e7790_8-k.htm"},"events":[{"id":18711,"run_id":16830,"accession_number":"0001731122-26-000957","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"summary":"The Company disclosed receipt of a Nasdaq deficiency notification for failure to timely file its Form 10-Q, triggering non-compliance with Nasdaq Listing Rule 5250(c)(1). While the Company submitted a Compliance Plan and trading continues, the filing directly addresses a material delisting risk — the Company faces potential delisting if the Compliance Plan is rejected and it cannot regain compliance. This is a core delisting-risk disclosure under Item 3.01 principles, disclosed here under Item 8.01.","company_name":"ANAVEX LIFE SCIENCES CORP.","ticker":"AVXL","filing_date":"2026-07-20","form":"8-K","submitted_at":null,"items":[{"id":17602,"accession_number":"0001731122-26-000957","item_number":"8.01","item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The Company disclosed receipt of a Nasdaq deficiency notification for failure to timely file its Form 10-Q, triggering non-compliance with Nasdaq Listing Rule 5250(c)(1). While the Company submitted a Compliance Plan and trading continues, the filing directly addresses a material delisting risk — the Company faces potential delisting if the Compliance Plan is rejected and it cannot regain compliance. This is a core delisting-risk disclosure under Item 3.01 principles, disclosed here under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-20T13:17:52.775988+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17602,"accession_number":"0001731122-26-000957","item_number":"8.01","item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The Company disclosed receipt of a Nasdaq deficiency notification for failure to timely file its Form 10-Q, triggering non-compliance with Nasdaq Listing Rule 5250(c)(1). While the Company submitted a Compliance Plan and trading continues, the filing directly addresses a material delisting risk — the Company faces potential delisting if the Compliance Plan is rejected and it cannot regain compliance. This is a core delisting-risk disclosure under Item 3.01 principles, disclosed here under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-20T13:17:52.775988+00:00","company_name":"ANAVEX LIFE SCIENCES CORP.","ticker":"AVXL","filing_date":"2026-07-20"}]}